Follow
Yangjianchen Xu
Title
Cited by
Cited by
Year
Effectiveness of bivalent boosters against severe omicron infection
DY Lin, Y Xu, Y Gu, D Zeng, B Wheeler, H Young, SK Sunny, Z Moore
New England Journal of Medicine 388 (8), 764-766, 2023
1702023
Association of primary and booster vaccination and prior infection with SARS-CoV-2 infection and severe COVID-19 outcomes
DY Lin, Y Gu, Y Xu, B Wheeler, H Young, SK Sunny, Z Moore, D Zeng
Jama 328 (14), 1415-1426, 2022
952022
Durability of bivalent boosters against Omicron subvariants
DY Lin, Y Xu, Y Gu, D Zeng, SK Sunny, Z Moore
New England Journal of Medicine 388 (19), 1818-1820, 2023
722023
Effects of vaccination and previous infection on omicron infections in children
DY Lin, Y Gu, Y Xu, D Zeng, B Wheeler, H Young, SK Sunny, Z Moore
New England Journal of Medicine 387 (12), 1141-1143, 2022
492022
Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort …
DY Lin, Y Xu, Y Gu, D Zeng, B Wheeler, H Young, Z Moore, SK Sunny
The Lancet Infectious Diseases 23 (11), 1257-1265, 2023
16*2023
Marginal proportional hazards models for multivariate interval-censored data
Y Xu, D Zeng, DY Lin
Biometrika 110 (3), 815-830, 2023
22023
Impact of Booster Vaccination Interval on SARS-CoV-2 Infection, Hospitalization, and Death
DY Lin, Y Xu, Y Gu, SK Sunny, Z Moore, D Zeng
International Journal of Infectious Diseases, 107084, 2024
2024
Proportional rates models for multivariate panel count data
Y Xu, D Zeng, DY Lin
Biometrics 80 (1), ujad011, 2024
2024
Effectiveness of Bivalent Boosters Over Nine and Half Months
S Paritala, Y Xu, Y Du, M Donahue, P Maloney, DY Lin
Journal of Biotechnology and Biomedicine 6, 585-589, 2023
2023
A Cost-Benefit Analysis of Bivalent Covid-19 Vaccines
DY Lin, Y Xu, D Zeng, SK Sunny
Journal of biotechnology and biomedicine 6 (4), 551, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–10